First Majestic Q2 production edges up, but thesis hinges on dividend and capex

What happened

First Majestic reported Q2 2026 production of 3.8M silver ounces, up 3% YoY, and updated its annual guidance. The results align with the company's operational plan but do not directly address the key investor concerns highlighted in our prior analysis. The market's focus remains on the upcoming May dividend decision under the new 2% revenue-linked framework and whether 2026 capex will stay within the $213-236M guided range. While the production increase provides a modest positive, it does not shift the risk-reward calculus given the high valuation (P/E ~63) and the discretionary nature of the payout. Investors should wait for the dividend declaration and capex updates before adjusting positions.

Implication

The Q2 production report is a non-event for the thesis; production growth is in line with expectations. The critical catalysts remain the May 2026 dividend payment (first under the 2% revenue formula) and subsequent capex disclosure. Until these are confirmed, the stock is priced as a high-beta silver proxy with no company-specific margin of safety. If the dividend is paid as advertised and capex holds, the stock could rerate toward $24 base case. If not, downside to $14 is possible. Maintain WAIT rating.

Thesis delta

Q2 production beat is incremental but does not alter the fundamental thesis. The main risks—dividend credibility and capital discipline—remain unresolved. The next 3-6 months will be dominated by these catalysts, not production headlines.